Vol 2, No 3 (2017)
Original paper
Published online: 2017-12-28

open access

Page views 840
Article views/downloads 945
Get Citation

Connect on Social Media

Connect on Social Media

Fundus autofluorescence and multicolour imaging comparison in assessing disease severity in patients suffering from geographic atrophy. A case series analysis

Ioannis Mallias1, Panagiota Mylova, Anastasia Tassiopoulou
Ophthalmol J 2017;2(3):69-78.

Abstract

INTRODUCTION. The aim of the study is to determine which depicting modality, fundus autofluorescence or multicolour imaging, is a better diagnostic tool in the monitoring of the progression of geographic atrophy in patients with severe dry macular degeneration. MATERIAL AND METHODS. Fifty patients (93 eyes) participated in this study. OCT examination (Spectralis HRA + OCT, Heidelberg Engineering, Germany) was performed in order to confirm that they fit the criteria to proceed in the study. In all patients, fundus autofluorescence and multicolour imaging was performed. RESULTS. The area of geographic atrophy was depicted with both modalities and useful information was obtained. In some cases, multicolour imaging provided more useful clues and in other cases the fundus autofluorescence provided useful information for the progression of the disease. CONCLUSIONS. Both modalities provide a wide range of useful information about the progression of geographic atrophy in patients with severe dry age-related macular degeneration and should both be performed in order to gather all the useful information about the disease progression.

Article available in PDF format

View PDF Download PDF file

References

  1. Coleman HR, Chan CC, Ferris FL, et al. Age-related macular degeneration. Lancet. 2008; 372(9652): 1835–1845.
  2. Girmens JF, Sahel JA, Marazova K. Dry age-related macular degeneration: A currently unmet clinical need. Intractable Rare Dis Res. 2012; 1(3): 103–114.
  3. Gregory S. Hageman, Karen Gehrs, Lincoln V. Johnson, and Don Anderson, Age-Related Macular Degeneration (AMD), Webvision: The Organization of the Retina and Visual System [Internet].
  4. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med. 2008; 358(24): 2606–2617.
  5. Rickman CB, Farsiu S, Toth C, et al. Dry age-related macular degeneration: Mechanisms, therapeutic targets, and imaging. Investigative Opthalmology & Visual Science. 2013; 54(14): ORSF68.
  6. Taskintuna I, Elsayed ME, Schatz P. Update on cinical trials in dry age-related macular degeneration. Middle East Afr J Ophthalmol. 2016; 23(1): 13–26.
  7. Zhang GuM, Chen Y. Pathogenesis of dry age-related macular degeneration: updates. Zhonghua Yan Ke Za Zhi. 2014; 50(6): 464–470.
  8. Nowak JZ. AMD — the retinal disease with an unprecised etiopathogenesis: in search of effective therapeutics. Acta Pol Pharm. 2014; 71(6): 900–916.
  9. Klein R, Klein B, Moss S, et al. The Beaver Dam Eye Study. Ophthalmology. 1992; 99(1): 58–62.
  10. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 2004; 122(4): 598–614.
  11. Zając-Pytrus HM, Pilecka A, Turno-Kręcicka A, et al. The dry form of age-related macular degeneration (AMD): The current concepts of pathogenesis and prospects for treatment. Adv Clin Exp Med. 2015; 24(6): 1099–1104.
  12. Kovalevskaya MA, Milyutkina SO. Efficacy of conservative treatment in patients with dry form of age-related macular degeneration. Vestn Oftalmol. 2015; 131(2): 81–88.
  13. Waheed NK, Moult EM, Fujimoto JG, et al. Optical coherence tomography angiography of dry age-related macular degeneration. Dev Ophthalmol. 2016; 56: 91–100.
  14. Chong EWT, Kreis AJ, Wong TY, et al. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol. 2008; 126(6): 826–833.
  15. Bearelly S, Cousins SW. Fundus autofluorescence imaging in age-related macular degeneration and geographic atrophy. Adv Exp Med Biol. 2010; 664: 395–402.
  16. Batıoğlu F, Demirel S, Özmert E. Fundus autofluorescence imaging in age-related macular degeneration. Semin Ophthalmol. 2015; 30(1): 65–73.
  17. Ly A, Nivison-Smith L, Assaad N, et al. Fundus autofluorescence in age-related macular degeneration. Optom Vis Sci. 2017; 94(2): 246–259.
  18. http://www.roche.com/media/store/releases/med-cor-2017-09-08b.htm.
  19. Scharioth GB. New add-on intraocular lens for patients with age-related macular degeneration. J Cataract Refract Surg. 2015; 41(8): 1559–1563.
  20. Nekolova J, Rozsival P, Sin M, et al. Scharioth Macula Lens: A new intraocular implant for low-vision patients with stabilized maculopathy- first experience. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017; 161(2): 206–209.
  21. Colby KA, Chang DF, Stulting RD, et al. Surgical placement of an optical prosthetic device for end-stage macular degeneration: the implantable miniature telescope. Arch Ophthalmol. 2007; 125(8): 1118–1121.
  22. Boyer D, Freund KB, Regillo C, et al. Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration. Clin Ophthalmol. 2015; 9: 1099–1107.
  23. Yamamoto M, Kohno T, Shiraki K. Comparison of fundus autofluorescence of age-related macular degeneration between a fundus camera and a confocal scanning laser ophthalmoscope. Osaka City Med J. 2009; 55(1): 19–27.
  24. Deli A, Moetteli L, Ambresin A, et al. Comparison of fundus autofluorescence images acquired by the confocal scanning laser ophthalmoscope (488 nm excitation) and the modified Topcon fundus camera (580 nm excitation). Int Ophthalmol. 2013; 33(6): 635–643.
  25. Park SP, Siringo FS, Pensec N, et al. Comparison of fundus autofluorescence between fundus camera and confocal scanning laser ophthalmoscope-based systems. Ophthalmic Surg Lasers Imaging Retina. 2013; 44(6): 536–543.
  26. Khanifar AA, Lederer DE, Ghodasra JH, et al. Comparison of color fundus photographs and fundus autofluorescence images in measuring geographic atrophy area. Retina. 2012; 32(9): 1884–1891.
  27. Sayegh RG, Simader C, Scheschy U, et al. A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy. Ophthalmology. 2011; 118(9): 1844–1851.
  28. Simader C, Sayegh RG, Montuoro A, et al. A longitudinal comparison of spectral-domain optical coherence tomography and fundus autofluorescence in geographic atrophy. Am J Ophthalmol. 2014; 158(3): 557–66.e1.
  29. Graham KW, Chakravarthy U, Hogg RE, et al. Identifying features of early and late age-related macular degeneration: A comparison of multicolor versus traditional color fundus photography. Retina. 2017 [Epub ahead of print].